MedPath

The influence teatment of acupuncture and moxibution gives it to breast cancer postoperation immunity

Not Applicable
Conditions
After the breast cancer operation under chemoterapy
Registration Number
JPRN-UMIN000042462
Lead Sponsor
mizushima clinic
Brief Summary

It was Th1/Th2 20.4/4.9 before treatment in the acupuncture group ,but Th1/Th2 30.2/3.0 after treatment 10years .It was Th1/Th2 21.5/5.0 before non-treatment in the acupuncture group but Th1/Th2 20.6/5.2 become after10years. The relapse rate after 10years did not accept significant difference in stage1 (both relapse rate0%), but acupuncture treatment group in stage2-4 was dominant relapse rate decreased (rate 21.4%) for non-treatment group (rate 66.6%)

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
51
Inclusion Criteria

Not provided

Exclusion Criteria

Cases in which informed consent could not be obtained

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
10years late brest cancer recurrence rate
Secondary Outcome Measures
NameTimeMethod
White blood cell and lynphocyte Th1/Th2 CA 15-3 and Treg measure every 3 months
© Copyright 2025. All Rights Reserved by MedPath